- Home
- OVV vs MRNA Comparison
OVV vs MRNA Comparison
Compare OVV & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OVV
- MRNA
- Stock Information
- Founded
- OVV 2020
- MRNA 2010
- Country
- OVV United States
- MRNA United States
- Employees
- OVV N/A
- MRNA N/A
- Industry
- OVV Oil & Gas Production
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OVV Energy
- MRNA Health Care
- Exchange
- OVV Nasdaq
- MRNA Nasdaq
- Market Cap
- OVV 9.8B
- MRNA 10.6B
- IPO Year
- OVV N/A
- MRNA 2018
- Fundamental
- Price
- OVV $41.51
- MRNA $25.90
- Analyst Decision
- OVV Strong Buy
- MRNA Hold
- Analyst Count
- OVV 14
- MRNA 19
- Target Price
- OVV $53.92
- MRNA $48.13
- AVG Volume (30 Days)
- OVV 4.5M
- MRNA 10.5M
- Earning Date
- OVV 07-29-2025
- MRNA 07-31-2025
- Dividend Yield
- OVV 2.89%
- MRNA N/A
- EPS Growth
- OVV N/A
- MRNA N/A
- EPS
- OVV 2.38
- MRNA N/A
- Revenue
- OVV $8,931,000,000.00
- MRNA $3,177,000,000.00
- Revenue This Year
- OVV N/A
- MRNA N/A
- Revenue Next Year
- OVV N/A
- MRNA $9.87
- P/E Ratio
- OVV $17.44
- MRNA N/A
- Revenue Growth
- OVV N/A
- MRNA N/A
- 52 Week Low
- OVV $29.80
- MRNA $23.15
- 52 Week High
- OVV $49.57
- MRNA $138.07
- Technical
- Relative Strength Index (RSI)
- OVV 66.28
- MRNA 46.10
- Support Level
- OVV $39.22
- MRNA $25.06
- Resistance Level
- OVV $41.06
- MRNA $28.72
- Average True Range (ATR)
- OVV 1.21
- MRNA 1.18
- MACD
- OVV 0.33
- MRNA -0.18
- Stochastic Oscillator
- OVV 87.62
- MRNA 20.34
About OVV Ovintiv Inc. (DE)
Ovintiv Inc is a North American oil and natural gas exploration and production company that is focused on developing its multi-basin portfolio of high-quality assets located in the United States and Canada. Its operations also include the marketing of oil, NGLs and natural gas. The company has two operating segments: USA Operations, and Canadian Operations. The USA Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within the United States. The Canadian Operations include the exploration for, development of, and production and marketing of oil, NGLs, natural gas and other related activities within Canada.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.